Prelude Capital Management’s LeonaBio Inc LONA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-1,100
Closed -$3.13K – 1013
2025
Q1
$3.13K Hold
1,100
– – ﹤0.01% 1140
2024
Q4
$6.45K Hold
1,100
– – ﹤0.01% 1175
2024
Q3
$4.91K Sell
1,100
-694
-39% -$16.3K ﹤0.01% 1239
2024
Q2
$47.5K Sell
1,794
-573
-24% -$13.5K ﹤0.01% 1148
2024
Q1
$64.8K Sell
2,367
-775
-25% -$24.6K ﹤0.01% 1240
2023
Q4
$76.4K Sell
3,142
-50
-2% -$887 0.01% 1048
2023
Q3
$64.5K Buy
3,192
+320
+11% +$8.2K ﹤0.01% 1028
2023
Q2
$84.7K Sell
2,872
-1,424
-33% -$40.6K 0.01% 943
2023
Q1
$107K Sell
4,296
-1,976
-32% -$63.6K 0.01% 946
2022
Q4
$199K Buy
6,272
+150
+2% +$4.73K 0.01% 973
2022
Q3
$182K Buy
6,122
+2,942
+93% +$102K 0.01% 1096
2022
Q2
$97K Buy
3,180
+2,080
+189% +$191K ﹤0.01% 1424
2022
Q1
$149K Buy
+1,100
New +$116K ﹤0.01% 1335
2021
Q4
– Sell
-1,040
Closed -$98K – 1976
2021
Q3
$98K Buy
+1,040
New +$106K ﹤0.01% 1502

Other funds holding LONA

Prelude Capital Management's LONA Position: Q2 2025 in Review

Prelude Capital Management sold out of LeonaBio Inc (LONA) in Q2 2025, closing a stake of 1,100 shares — an estimated $3.13K sold.

Prelude Capital Management first reported a position in LONA in Q3 2021 and held it in 14 quarters. The position peaked at $199K in Q4 2022. 50 funds tracked by Wall St. Rank hold LONA as of Q2 2025.

  • Prelude Capital Management reported no remaining LeonaBio Inc position as of Q2 2025 after selling out during the quarter.
  • Prelude Capital Management sold 1,100 LeonaBio Inc shares in Q2 2025, an estimated $3.13K.
  • Prelude Capital Management first reported a position in LeonaBio Inc in Q3 2021 and held it in 14 quarters.
  • Prelude Capital Management's LeonaBio Inc position peaked at $199K in Q4 2022.
  • 50 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.